NCT01750723View on ClinicalTrials.gov

Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
HeadacheMigraine
Interventions
DRUG

Acetazolamide

1 g diluted in 10 ml saline, i.v. bolus injection.

Trial Locations (2)

2600

Danish Headache Center, Copenhagen

Department of Neurology, Copenhagen

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT01750723 - Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow | Biotech Hunter | Biotech Hunter